SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001599298-24-000105
Filing Date
2024-06-27
Accepted
2024-06-27 17:16:23
Documents
4
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1719522974.html 3  
1 FORM 3 wk-form3_1719522974.xml 3 2778
2 EX-24 poasec16-jeffreyhubercon.htm EX-24 5147
3 poasec16-jeffreyhubercon001.jpg GRAPHIC 273518
4 poasec16-jeffreyhubercon002.jpg GRAPHIC 35082
  Complete submission text file 0001599298-24-000105.txt   434730
Mailing Address 209 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address
Huber Jeff (Reporting) CIK: 0001463740 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 241080413

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)